Clinical trial
Verapamil Effect in Cystic Fibrosis-related Dysglycemia
NCT07688070
Study timeline
Study start (estimated)2026-08-01Date precision: day
Registry last updated2026-07-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cystic Fibrosis Related Diabetesunresolved
Cystic Fibrosis (CF)unresolved
Abnormal Glucose Toleranceunresolved
Interventions
Verapamil HydrochlorideDRUG · verified · RxNorm: verapamil hydrochloride
Sponsors & collaborators
Rhode Island Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07688070 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.